Dr. Kirsten Greene, MD

Dr. Greene practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Greene's NPI, 1023119013, was assigned on September 25, 2006. Dr. Greene graduated from The Johns Hopkins University School of Medicine in 2000. Dr. Greene holds Virginia license 0101267898.

Dr. Greene's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 924-2762.

Dr. Greene's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Greene is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Greene to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greene practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Greene's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Greene is board certified in urology by the American Board of Urology. Dmand AI has Dr. Greene's licenses on file in 2 states: Virginia and California.

Dmand AI lists enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Dr. Greene treats.

CMS data shows 854 Medicare services from Dr. Greene across 12 procedure codes in 2024, for 368 Medicare patients. Medicare paid $66,557 for them.

CMS counts 368 Medicare patients who saw Dr. Greene in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have cancer, and 73% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greene's median patient age at 69, with 15% women.

In 2024, Dr. Greene wrote 193 Medicare Part D claims for 78 patients. 96% of them were for generic drugs. CMS names the drug for 122 of them, across 2 drugs with 11 or more claims each, at $1,743 in total drug cost. In 2023, CMS named 69 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Greene for performance year 2024, reported as part of a group. Dr. Greene accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Greene as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 67 papers to Dr. Greene, published from 2010 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, Urology and Internship and Residency. Dr. Greene has published most often in Urology. Dr. Greene's most frequent co-authors are Peter R. Carroll, MD, Matthew R. Cooperberg, MD and Maxwell V. Meng, MD.

CMS Open Payments shows 35 general payments to Dr. Greene from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Ethicon Inc. paid the most, $15,183.

Dmand AI lists 2 awards for Dr. Greene, most recently CMS Stage 1 EHR in 2012.

Dr. Greene graduated from The Johns Hopkins University School of Medicine in 2000. Dr. Greene is a member of ACS.

Dr. Greene is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.